COVID-19 in Sudan

Ayman Ahmed; Nouh Saad Mohamed; Sarah Misbah EL-Sadig; Lamis  Ahmed Fahal; Ziad Bakri  Abelrahim; Eiman Siddig Ahmed; Emmanuel Edwar Siddig

doi:10.3855/jidc.14520

COVID-19 in Sudan

Authors

Ayman Ahmed Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan
Nouh Saad Mohamed Department of Molecular Biology, Faculty of Medical Laboratory Sciences, Nile University, Khartoum, Sudan
Sarah Misbah EL-Sadig Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
Lamis Ahmed Fahal Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan
Ziad Bakri Abelrahim Ribat Teaching Hospital, COVID-19 Isolation Centre, Khartoum, Sudan
Eiman Siddig Ahmed Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan
Emmanuel Edwar Siddig Mycetoma Research Centre, University of Khartoum, Khartoum, Sudan

DOI:

https://doi.org/10.3855/jidc.14520

Keywords:

COVID-19, Sudan, Preventive measures, deaths, cases

Abstract

The steadily growing COVID-19 pandemic is challenging health systems worldwide including Sudan. In Sudan, the first COVID-19 case was reported on 13th March 2020, and up to 11 November 2020 there were 14,401 confirmed cases of which 9,535 cases recovered and the rest 3,750 cases were under treatment. Additionally, 1,116 deaths were reported, indicating a relatively high case fatality rate of 7.7%. Several preventive and control measures were implemented by the government of Sudan and health partners, including the partial lockdown of the country, promoting social distancing, and suspending mass gathering such as festivals and performing religious practices in groups. However, new cases still emerging every day and this could be attributed to the noncompliance of the individuals to the advocated preventive measurements.

Downloads

Published

2021-03-07

How to Cite

Ahmed A, Mohamed NS, EL-Sadig SM, Fahal LA, Abelrahim ZB, Ahmed ES, Siddig EE (2021) COVID-19 in Sudan. J Infect Dev Ctries 15:204–208. doi: 10.3855/jidc.14520

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 15 No. 02: February 2021

Section

Coronavirus Pandemic

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).